Article ID Journal Published Year Pages File Type
5737442 Neuroscience 2017 12 Pages PDF
Abstract

•NEX-Pten mutant forebrain neurons exhibit a hypertrophic phenotype and activation of the PI3K/Akt/mTOR pathway.•The mTORC1 inhibitor RAD001 partially rescues the hypertrophy, whereas the Akt inhibitor MK-2206 completely suppresses it.•Neither RAD001 nor MK-2206 affects the size of normal neurons.•Akt inhibition may be a viable strategy to restore normal neuronal size in patients with brain overgrowth syndromes.

Mutations in the PI3K/Akt/mTOR signaling pathway or in the upstream negative regulator Pten cause human brain overgrowth disorders, such as focal cortical dysplasia and megalencephaly, and are characterized by the presence of hypertrophic neurons. These disorders often have a pediatric onset and a high comorbidity with drug-resistant epilepsy; however, effective pharmacological treatments are lacking. We established forebrain excitatory neuron-specific Pten-deficient cultures as an in vitro model of brain overgrowth disorders, and investigated the effects of this Pten mutation on PI3K/Akt/mTOR signaling and neuronal growth. Mutant neurons exhibit excessive PI3K/Akt/mTOR signaling activity, enlarged somas and increased dendritic arborization. To understand the contributions of Akt and mTORC1 kinases to the hypertrophy phenotype, we evaluated the effects of short-term treatment with the Akt inhibitor MK-2206, and the mTORC1 inhibitor RAD001, which have shown safety and efficacy in human cancer clinical trials. We found that RAD001 treatment only partially reversed the morphological abnormalities of Pten mutant neurons, whereas MK-2206 treatment completely rescued the phenotype. Interestingly, neither treatment altered the size or morphology of normal neurons. Our results suggest that Akt is a major determinant of neuronal growth, and that Akt inhibition may be an effective strategy for pharmacological intervention in brain overgrowth disorders.

Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (57 K)Download as PowerPoint slide

Related Topics
Life Sciences Neuroscience Neuroscience (General)